AEON
AEON clinical trials: AEON Biopharma, Inc.
Every trial on ClinicalTrials.gov where AEON Biopharma, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 4
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
AEON on the catalyst calendar · AEON registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Jul 31, 2024Actual | NCT05016661Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine PreventionAEON Biopharma, Inc. · Migraine | AEONLead | Phase 2 | Terminated | Locked | Locked | Locked |
| Jun 19, 2024Actual | NCT04845178Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in AdultsAEON Biopharma, Inc. · Migraine | AEONLead | Phase 2 | Completed | Locked | Locked | Locked |
| Jul 24, 2023Actual | NCT04871451Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical DystoniaAEON Biopharma, Inc. · Cervical Dystonia | AEONLead | Phase 2 | Completed | Locked | Locked | Locked |
| Jul 11, 2022Actual | NCT04849988A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical DystoniaAEON Biopharma, Inc. · Cervical Dystonia | AEONLead | Phase 2 | Completed | Locked | Locked | Locked |
- Primary completion Jul 31, 2024ActualPhase 2NCT05016661Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine PreventionAEON Biopharma, Inc. · MigraineTerminatedAEONLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 19, 2024ActualPhase 2NCT04845178Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in AdultsAEON Biopharma, Inc. · MigraineCompletedAEONLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 24, 2023ActualPhase 2NCT04871451Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical DystoniaAEON Biopharma, Inc. · Cervical DystoniaCompletedAEONLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 11, 2022ActualPhase 2NCT04849988A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical DystoniaAEON Biopharma, Inc. · Cervical DystoniaCompletedAEONLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner